Skip to main content

Table 2 NAT1 genotype frequency.

From: Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma

NAT1Genotype Sporadic-CRC IBD benign IBD dysplasia/cancer Control
  No. % No. % No. % No. %
NAT1*4/*4 73 59.35 205 55.7 9 60 131 58.75
NAT1*4/*10 28 22.77 104 28.3 6 40 61 27.35
NAT1*10/*10 9 7.32 18 4.89    9 4.03
NAT1*4/*14A or *10/*14B 4 3.25 13 3.53    7 3.14
NAT1*4/*11B 0 0 6 1.63    5 2.24
NAT1*4/*14B 2 1.63 3 0.81    2 0.9
NAT1*10/*11B 1 0.81 2 0.54    2 0.9
NAT1*4/*3 2 1.63 3 0.81    1 0.45
NAT1*4/*15 0 0 1 0.27    1 0.45
NAT1*4/*11A or *3/*11B 1 0.81 0 0    1 0.45
NAT1*3/*11A 0 0 0 0    1 0.45
NAT1*10/*15 0 0 0 0    1 0.45
NAT1*4/*17 0 0 6 1.63    1 0.44
NAT1*3/*3 1 0.81 2 0.54    0 0
NAT1*10/*17 0 0 2 0.54    0 0
NAT1*10/*22 1 0.81 1 0.27    0 0
NAT1*4/*22 0 0 1 0.27    0 0
NAT1*3/*14A 1 0.81 0 0    0 0
NAT14A/*22 0 0 1 0.27    0 0
Total 123   368   15   223  
  1. Genotypes listed by order of decreasing frequency in control group
  2. IBD: inflammatory bowel disease
  3. CRC: colorectal cancer